Delivery Order SPE2DB20D2002-SPE2DB24FL60E

Award Date 6/11/24
Potential Completion Date 6/12/24
Potential Value $9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,357.71 firm fixed-price delivery order is for the supply of Eliquis 5 mg tablets, a medication used for the treatment of various cardiovascular conditions. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a...
This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,684.24 firm-fixed-price delivery order contract is for the supply of Eliquis 5 mg tablets to support military healthcare programs. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,841.73 firm-fixed-price delivery order is for the supply of Eliquis 5 mg tablets, a medication used to treat and prevent blood clots. The contract has an ultimate completion date of September 12, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,923.34 firm-fixed-price delivery order is for the supply of Eliquis 2.5 mg tablets, a medication used to treat and prevent blood clots. The contract has an ultimate completion date of August 1, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,519.50 firm fixed-price delivery order is for the supply of Eliquis 5 mg tablets, a medication used for cardiovascular health. This award is under an Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,952.43 fixed-price delivery order is for the supply of Eliquis 5 mg tablets, a medication used to treat and prevent blood clots. The contract has an ultimate completion date of November 27, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,529.46 firm-fixed-price delivery order contract is for the supply of Eliquis 5 mg tablets. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which covers a comprehensive range of pharmaceutical products and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,397.36 firm fixed-price delivery order is for the supply of Eliquis 5 mg tablets, a medication used for blood clot prevention. The contract has an ultimate completion date of January 23, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $74,125.72 firm-fixed-price delivery order is for the supply of Eliquis 5 mg tablets, a medication used to treat and prevent blood clots. The contract has an ultimate completion date of October 18, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,353.74 firm fixed-price delivery order is for the supply of Eliquis 5 mg tablets, a cardiovascular medication. The contract has a period of performance through December 1, 2022 and was awarded on November 30, 2022. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
  • SPE2DB20D2002
    Indefinite Delivery Contract
  • SPE2DB20D2002-SPE2DB24FL60E
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,967.42 firm fixed-price delivery order is for the supply of Eliquis 5 mg tablets, a medication used to treat and prevent blood clots. This order is a part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition. In addition to the DLA contract, AmerisourceBergen also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation, covering similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 2/27/25, 10:14 AM